Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.

Aune G, Stunes AK, Tingulstad S, Salvesen O, Syversen U, Torp SH.

Int J Clin Exp Pathol. 2011 Jun 20;4(5):444-53. Epub 2011 Jun 11.

2.

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.

Ladstein RG, Bachmann IM, Straume O, Akslen LA.

BMC Cancer. 2010 Apr 14;10:140. doi: 10.1186/1471-2407-10-140.

3.

Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.

Varughese RK, Lind-Landström T, Habberstad AH, Salvesen Ø, Haug CS, Sundstrøm S, Torp SH.

J Clin Pathol. 2016 Jan;69(1):26-34. doi: 10.1136/jclinpath-2015-202983. Epub 2015 Jul 17.

PMID:
26188054
4.

Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.

Nielsen PS, Riber-Hansen R, Jensen TO, Schmidt H, Steiniche T.

Mod Pathol. 2013 Mar;26(3):404-13. doi: 10.1038/modpathol.2012.188. Epub 2012 Nov 23.

5.

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.

Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K.

Am J Surg Pathol. 2006 May;30(5):657-64.

PMID:
16699322
6.

Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.

Gunia S, Kakies C, Erbersdobler A, Koch S, May M.

J Clin Pathol. 2012 Aug;65(8):715-20. doi: 10.1136/jclinpath-2011-200532. Epub 2012 May 3.

PMID:
22554964
7.

Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.

Nasr MR, El-Zammar O.

Am J Dermatopathol. 2008 Apr;30(2):117-22. doi: 10.1097/DAD.0b013e3181624054.

PMID:
18360113
8.
9.

[Expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors].

Wang S, Ma XY, Xia Y, Zhang LH.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Jul;41(4):575-80. Chinese.

PMID:
20848772
11.

[Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].

Reitmaier M, Rudlowski C, Biesterfeld S, Rath W, Schröder W.

Zentralbl Gynakol. 2000;122(7):361-7. German.

PMID:
10951706
12.

Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.

Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M.

Int J Oncol. 2002 Aug;21(2):315-20.

PMID:
12118327
13.

Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases.

Ariyoshi K, Kawauchi S, Kaku T, Nakano H, Tsuneyoshi M.

Histopathology. 2000 Nov;37(5):427-36.

PMID:
11119124
14.

Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.

Kucukgoz Gulec U, Gumurdulu D, Guzel AB, Paydas S, Seydaoglu G, Acikalin A, Khatib G, Zeren H, Vardar MA, Altintas A.

Arch Gynecol Obstet. 2014 Feb;289(2):393-8. doi: 10.1007/s00404-013-3000-z. Epub 2013 Aug 22.

PMID:
23974278
15.

pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant.

Brunner A, Riss P, Heinze G, Brustmann H.

Br J Cancer. 2012 Jun 26;107(1):84-90. doi: 10.1038/bjc.2012.198. Epub 2012 May 29.

16.

Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.

Voss SM, Riley MP, Lokhandwala PM, Wang M, Yang Z.

Am J Surg Pathol. 2015 Jan;39(1):13-24. doi: 10.1097/PAS.0000000000000341.

PMID:
25353284
17.

Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome.

Fields AC, Cotsonis G, Sexton D, Santoianni R, Cohen C.

Mod Pathol. 2004 Nov;17(11):1378-85.

19.

Study of borderline and invasive mucinous ovarian tumors using Ki-67 (MIB 1) antibodies and nucleolar organizer region (NOR) staining.

Terlikowski S, Sulkowski S, Lenczewski A, Musiatowicz B, Kulikowski M.

Arch Gynecol Obstet. 1999 Nov;263(1-2):29-33.

PMID:
10728625
20.

Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.

Iwasaki T, Matsushita M, Nonaka D, Kato M, Nagata K, Murakami I, Hayashi K.

Pathol Int. 2015 Aug;65(8):404-9. doi: 10.1111/pin.12305. Epub 2015 May 18.

PMID:
25982855

Supplemental Content

Support Center